Muramyl dipeptide-Lys stimulates the function of human dendritic cells

Journal of Leukocyte Biology

Volumn 70, Issue 5, 2001, Pages 723-729

  Todate, Akihito ^a   Suda, Takafumi ^a   Kuwata, Hiroshi ^a   Chida, Kingo ^a,b   Nakamura, Hirotoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Antigen presenting cells; Immunoadjuvant activity; T cell immunity

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MURAMYL DIPEPTIDE DERIVATIVE; MURAMYL DIPEPTIDE LYSINE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL MEMBRANE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; DRUG ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; T LYMPHOCYTE;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANTIGEN PRESENTATION; ANTIGENS, CD; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; INTERLEUKINS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 0035213770     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
2. Adjuvant activity of monomeric bacterial cell wall peptidoglycans
3. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity
4. Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide
5. Influence of a muramyl dipeptide on human blood leukocyte functions and their membrane antigens
6. + mobilization or protein kinase C activation
7. Muramyl dipeptide (MDP) synergizes with interleukin-2 and interleukin-4 to stimulate, respectively, the differentiation and proliferation of B cells
8. Modulation of expression of class II MHC and CD40 molecules in murine B cells by various muramyl dipeptides
9. Bacterial cell wall products increase monocyte HLA-DR and ICAM-1 without affecting lymphocyte CD18 expression
10. Muroctasim: A new muramyl dipeptide derivative, MDP-Lys (L18)
11. Physico-chemical properties of muroctasin
12. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections
13. Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog
14. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice
15. Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine
16. Effect of N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine on resistance to herpes simplex virus type-1 infection in cyclophosphamide-treated mice
17. Effect of MDP-Lys (L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice
18. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen
19. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine
20. MDP-Lys(L18), a lipophilic derivative of nmramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice
21. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues
22. Differences in interleukin-I (IL-I), IL-6, tumor necrosis factor and IL-I receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide
23. The dendritic cell system and its role in immunogenicity
24. Dendritic cells and the control of immunity
25. Lymphoid dendritic cells
26. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10
27. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway
28. Dendritic cells as the terminal stage of monocyte differentiation
29. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
30. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids
31. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
32. Functions of CD40 on B cells, dendritic cells and other cells
33. Structure and evolution of the extended B7 family
34. Generation of mature dendritic cells from human blood - An improved method with special regard to clinical applicability
35. The effects of beryllium and other adjuvants on Ia expression by macrophages
36. Differential mRNA responses in human macrophages activated by interferon-gamma and muramyl dipeptide
37. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation
38. Tumor necrosis factor: A plurifunctional mediator of acute inflammation
39. Biological and clinical aspects of interleukin-6
40. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
41. Interleukin-12 and its role in the generation of Th1 cells
42. Biological properties of interleukin-10
43. IL-10 inhibits cytokine production by activated macrophages
44. Effect of interleukin-10 on dendritic cell maturation and function
45. Inducer of cytokines in vivo: Overview of field and romurtide experience
46. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
47. Toll-like receptors in the induction of the innate immune response
48. Toll-like receptor-mediated NF-kB activation: A phylogenetically conserved paradigm in innate immunity
49. Synergistic effect of muramyldipeptide with lipopolysaccaride or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture
50. Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release
51. The interaction of immunomodulator muramyl dipeptide with peripheral 5-HT receptors: Overview of the current state